Adma Biologics Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (28)

View All

Latest Posts

About This Stock More About This Stock
Chart Of The Day: ADMA Biologics - Hitting New Highs
Article By: Jim Van Meerten
Monday, May 6, 2024 11:23 AM EDT
100% technical buy signals 8 new highs and up 7.24% in the last month 110.10+ Weighted Alpha
In this article: ADMA
Read
Stocks That Made New Highs On Friday, Aug. 19
Article By: Fred Fuld III
Sunday, August 21, 2022 5:46 AM EDT
On Friday, in spite of the stock market being down, there were several stocks that actually made new highs.
In this article: NL, ARTNA, ICPT, SUPN, ADMA, AXSM
Read
4 Drug/Biotech Stocks Set To Outpace Q4 Earnings Estimates
Article By: Zacks Investment Research
Saturday, February 20, 2021 9:00 AM EDT
While almost all big drugmakers have reported their results, several smaller drug and biotech companies are yet to report this earnings season.
In this article: LXRX, MRNA, ADMA, BNTX Also: AVIR
Read
ADMA Biologics Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Saturday, June 9, 2018 2:00 AM EDT
ADMA Biologics, Inc. announced today the pricing of its previously announced underwritten public offering of 8,368,200 shares of its common stock at a public offering price of $4.78 per share.
In this article: ADMA
Read
ADMA Biologics: Almost Ready To Run Between The Toes Of Giants
Article By: Simon Daly
Tuesday, March 6, 2018 10:27 PM EDT
ADMA’s lead product candidate has positive data, positioned for high unmet medical need. The burden of lifting regulatory hold is lower than might be perceived by investors at present.
In this article: ADMA
Read
All Posts

Latest Tweets for $ADMA

No tweets yet!

PARTNER HEADLINES